{"status":"ok","message-type":"work","message-version":"1.0.0","message":{"indexed":{"date-parts":[[2026,10,23]],"date-time":"2026-10-23T22:15:34Z","timestamp":1792793734835,"version":"4.5.0"},"reference-count":49,"publisher":"Springer Science and Business Media LLC","issue":"2","license":[{"start":{"date-parts":[[2021,2,4]],"date-time":"2021-02-04T00:00:00Z","timestamp":1612396800000},"content-version":"tdm","delay-in-days":0,"URL":"https:\/\/www.springer.com\/tdm"},{"start":{"date-parts":[[2021,2,4]],"date-time":"2021-02-04T00:00:00Z","timestamp":1612396800000},"content-version":"vor","delay-in-days":0,"URL":"https:\/\/www.springer.com\/tdm"}],"funder":[{"DOI":"10.13039\/501100008108","name":"Taipei Tzu Chi Hospital","doi-asserted-by":"publisher","award":["TCRD-TPE-108-2"],"award-info":[{"award-number":["TCRD-TPE-108-2"]}],"id":[{"id":"10.13039\/501100008108","id-type":"DOI","asserted-by":"publisher"}]},{"name":"Taiwan Liver Disease Consortium, Ministry of Science and Technology, Taiwan","award":["109-2321-B-002 -034"],"award-info":[{"award-number":["109-2321-B-002 -034"]}]}],"content-domain":{"domain":["link.springer.com"],"crossmark-restriction":false},"short-container-title":["Hepatol Int"],"published-print":{"date-parts":[[2021,4]]},"DOI":"10.1007\/s12072-021-10147-0","type":"journal-article","created":{"date-parts":[[2021,2,4]],"date-time":"2021-02-04T13:04:54Z","timestamp":1612443894000},"page":"405-412","update-policy":"https:\/\/doi.org\/10.1007\/springer_crossmark_policy","source":"Crossref","is-referenced-by-count":31,"title":["The metabolic profiles and body composition of lean metabolic associated fatty liver disease"],"prefix":"10.1007","volume":"15","author":[{"given":"Yu-Ming","family":"Cheng","sequence":"first","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Jia-Horng","family":"Kao","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"ORCID":"https:\/\/orcid.org\/0000-0002-0827-4503","authenticated-orcid":false,"given":"Chia-Chi","family":"Wang","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]}],"member":"297","published-online":{"date-parts":[[2021,2,4]]},"reference":[{"key":"10147_CR1","doi-asserted-by":"publisher","DOI":"10.1007\/s12072-020-10094-2","author":"M Eslam","year":"2020","unstructured":"Eslam M, Sarin SK, Wong VW, Fan JG, Kawaguchi T, Ahn SH, et al. The Asian Pacific association for the study of the liver clinical practice guidelines for the diagnosis and management of metabolic associated fatty liver disease. Hepatol Int 2020.https:\/\/doi.org\/10.1007\/s12072-020-10094-2.","journal-title":"Hepatol Int"},{"issue":"7","key":"10147_CR2","doi-asserted-by":"crossref","first-page":"1999","DOI":"10.1053\/j.gastro.2019.11.312","volume":"158","author":"M Eslam","year":"2020","unstructured":"Eslam M, Sanyal AJ, George J. International consensus panel MAFLD: a consensus-driven proposed nomenclature for metabolic associated fatty liver disease. Gastroenterology 2020;158(7):1999\u20132014 (e1)","journal-title":"Gastroenterology"},{"issue":"1","key":"10147_CR3","doi-asserted-by":"crossref","first-page":"202","DOI":"10.1016\/j.jhep.2020.03.039","volume":"73","author":"M Eslam","year":"2020","unstructured":"Eslam M, Newsome PN, Sarin SK, Anstee QM, Targher G, Romero-Gomez M, et al. A new definition for metabolic dysfunction-associated fatty liver disease: an international expert consensus statement. J Hepatol 2020;73(1):202\u2013209","journal-title":"J Hepatol"},{"key":"10147_CR4","doi-asserted-by":"crossref","first-page":"11","DOI":"10.1038\/nrgastro.2017.109","volume":"15","author":"Z Younossi","year":"2018","unstructured":"Younossi Z, Anstee QM, MariettiM HT, HenryL E, et al. Global burden of NAFLD and NASH: trends, predictions, risk factors and prevention. Nat Rev Gastroenterol Hepatol 2018;15:11\u201320","journal-title":"Nat Rev Gastroenterol Hepatol"},{"issue":"8","key":"10147_CR5","doi-asserted-by":"crossref","first-page":"1136","DOI":"10.1002\/hep4.1534","volume":"4","author":"P Golabi","year":"2020","unstructured":"Golabi P, Paik JM, Arshad T, Younossi Y, Mishra A, Younossi ZM. Mortality of NAFLD according to the body composition and presence of metabolic abnormalities. Hepatol Commun 2020;4(8):1136\u20131148","journal-title":"Hepatol Commun"},{"key":"10147_CR6","doi-asserted-by":"crossref","first-page":"665","DOI":"10.4103\/2230-8210.113758","volume":"17","author":"R Kumar","year":"2013","unstructured":"Kumar R, Rastogi A, Sharma MK, Bhatia V, Garg H, Bihari C, et al. Clinicopathological characteristics and metabolic profiles of non-alcoholic fatty liver disease in Indian patients with normal body mass index: do they differ from obese or overweight non-alcoholic fatty liver disease? Indian J Endocrinol Metab 2013;17:665\u2013671","journal-title":"Indian J Endocrinol Metab"},{"key":"10147_CR7","doi-asserted-by":"crossref","first-page":"1352","DOI":"10.1017\/S0007114516000386","volume":"115","author":"Z Hl","year":"2016","unstructured":"Hl Z, Wang NJ, Han B, Li Q, Chen Y, Zhu CF, et al. Low vitamin D levels and non-alcoholic fatty liver disease, evidence for their independent association in men in East China: a cross-sectional study [Survey on Prevalence in East China for metabolic diseases and risk factors (SPECT-China)]. Br J Nutr 2016;115:1352\u20131359","journal-title":"Br J Nutr"},{"key":"10147_CR8","doi-asserted-by":"crossref","first-page":"6765856","DOI":"10.1155\/2017\/6765856","volume":"2017","author":"H Cicho\u017c-Lach","year":"2017","unstructured":"Cicho\u017c-Lach H, Michalak A. A comprehensive review of bioelectrical impedance analysis and other methods in the assessment of nutritional status in patients with liver cirrhosis. Gastroenterol Res Pract 2017;2017:6765856","journal-title":"Gastroenterol Res Pract"},{"key":"10147_CR9","doi-asserted-by":"crossref","first-page":"102","DOI":"10.1038\/ajg.2016.318","volume":"112","author":"A Feldman","year":"2017","unstructured":"Feldman A, Eder SK, Felder TK, Kedenko L, Paulweber B, Stadlmayr A, et al. Clinical and metabolic characterization of lean caucasian subjects with non-alcoholic fatty liver. Am J Gastroenterol 2017;112:102\u2013110","journal-title":"Am J Gastroenterol"},{"issue":"8","key":"10147_CR10","first-page":"51","volume":"68","author":"P Shah","year":"2020","unstructured":"Shah P, Rathi P, Mandot A, Pal A, Ahire D. Study and comparison of metabolic profile of lean and obese subjects with non alcoholic fatty liver disease. J Assoc Physicians India 2020;68(8):51\u201354","journal-title":"J Assoc Physicians India"},{"key":"10147_CR11","doi-asserted-by":"crossref","first-page":"1317","DOI":"10.1002\/hep.21178","volume":"43","author":"RK Sterling","year":"2006","unstructured":"Sterling RK, Lissen E, Clumeck N, Sola R, Correa MC, Montaner J, et al. Development of a simple noninvasive index to predict significant fibrosis in patients with HIV\/HCV coinfection. Hepatology 2006;43:1317\u20131325","journal-title":"Hepatology"},{"key":"10147_CR12","doi-asserted-by":"crossref","first-page":"923","DOI":"10.1016\/j.jfma.2015.07.004","volume":"114","author":"C-C Wang","year":"2015","unstructured":"Wang C-C, Liu C-H, Lin C-L, Wang P-C, Tseng T-C, Lin HH, et al. Fibrosis index based on four factors better predicts advanced fibrosis or cirrhosis than aspartate aminotransferase\/platelet ratio index in chronic hepatitis C patients. J Formos Med Assoc 2015;114:923\u2013928","journal-title":"J Formos Med Assoc"},{"key":"10147_CR13","doi-asserted-by":"crossref","first-page":"434","DOI":"10.3390\/nu9050434","volume":"9","author":"YW Wang","year":"2017","unstructured":"Wang YW, Lin TY, Peng CH, Huang JL, Hung SC. Factors associated with decreased lean tissue index in patients with chronic kidney disease. Nutrients 2017;9:434","journal-title":"Nutrients"},{"issue":"3","key":"10147_CR14","doi-asserted-by":"crossref","first-page":"703","DOI":"10.1038\/ki.2013.336","volume":"85","author":"SC Hung","year":"2014","unstructured":"Hung SC, Kuo KL, Peng CH, Wu CH, Lien YC, Wang YC, et al. Volume overload correlates with cardiovascular risk factors in patients with chronic kidney disease. Kidney Int 2014;85(3):703\u2013709","journal-title":"Kidney Int"},{"issue":"7","key":"10147_CR15","doi-asserted-by":"crossref","first-page":"953","DOI":"10.1002\/hep4.1519","volume":"4","author":"S Young","year":"2020","unstructured":"Young S, Tariq R, Provenza J, Satapathy SK, Faisal K, Choudhry A, et al. Prevalence and profile of nonalcoholic fatty liver disease in lean adults: systematic review and meta-analysis. Hepatol Commun 2020;4(7):953\u2013972","journal-title":"Hepatol Commun"},{"issue":"4","key":"10147_CR16","doi-asserted-by":"crossref","first-page":"378","DOI":"10.1097\/MCG.0000000000001270","volume":"54","author":"Y Shi","year":"2020","unstructured":"Shi Y, Wang Q, Sun Y, Zhao X, Kong Y, Ou X, et al. The prevalence of lean\/nonobese nonalcoholic fatty liver disease: a systematic review and meta-analysis. J Clin Gastroenterol 2020;54(4):378\u2013387","journal-title":"J Clin Gastroenterol"},{"issue":"8","key":"10147_CR17","doi-asserted-by":"crossref","first-page":"739","DOI":"10.1016\/S2468-1253(20)30077-7","volume":"5","author":"Q Ye","year":"2020","unstructured":"Ye Q, Zou B, Yeo YH, Li J, Huang DQ, Wu Y, et al. Global prevalence, incidence, and outcomes of non-obese or lean non-alcoholic fatty liver disease: a systematic review and meta-analysis. Lancet Gastroenterol Hepatol 2020;5(8):739\u2013752","journal-title":"Lancet Gastroenterol Hepatol"},{"key":"10147_CR18","doi-asserted-by":"crossref","first-page":"1215","DOI":"10.1111\/j.1365-2036.2006.03112.x","volume":"24","author":"VW Wong","year":"2006","unstructured":"Wong VW, Hui AY, Tsang SW, Chan JLY, Wong GLH, Chan AWH, et al. Prevalence of undiagnosed diabetes and postchallenge hyperglycaemia in Chinese patients with non-alcoholic fatty liver disease. Aliment Pharmacol Ther 2006;24:1215\u20131222","journal-title":"Aliment Pharmacol Ther"},{"key":"10147_CR19","doi-asserted-by":"publisher","DOI":"10.1111\/jgh.15156","author":"FB Lu","year":"2020","unstructured":"Lu FB, Zheng KI, Rios RS, Targher G, Byrne CD, Zheng MH. Global epidemiology of lean non-alcoholic fatty liver disease: a systematic review and meta-analysis. J Gastroenterol Hepatol 2020 https:\/\/doi.org\/10.1111\/jgh.15156.","journal-title":"J Gastroenterol Hepatol"},{"key":"10147_CR20","doi-asserted-by":"crossref","first-page":"319","DOI":"10.1097\/MD.0b013e3182779d49","volume":"91","author":"ZM Younossi","year":"2012","unstructured":"Younossi ZM, Stepanova M, Negro F, Hallaji S, Younossi Y, Lam B, et al. Nonalcoholic fatty liver disease in lean individuals in the United States. Med (Baltim) 2012;91:319\u2013327","journal-title":"Med (Baltim)"},{"key":"10147_CR21","doi-asserted-by":"crossref","first-page":"1011","DOI":"10.1111\/hepr.12648","volume":"46","author":"Y Honda","year":"2016","unstructured":"Honda Y, Yoneda M, Kessoku T, Ogawa Y, Tomeno W, Imajo K, et al. Characteristics of non-obese non-alcoholic fatty liver disease: effect of genetic and environmental factors. Hepatol Res 2016;46:1011\u20131018","journal-title":"Hepatol Res"},{"key":"10147_CR22","doi-asserted-by":"crossref","first-page":"17932","DOI":"10.3748\/wjg.v20.i47.17932","volume":"20","author":"RN Feng","year":"2014","unstructured":"Feng RN, Du SS, Wang C, Li YC, Liu LY, Guo FC, et al. Lean-non-alcoholic fatty liver disease increases risk for metabolic disorders in a normal weight Chinese population. World J Gastroenterol 2014;20:17932\u201317940","journal-title":"World J Gastroenterol"},{"key":"10147_CR23","doi-asserted-by":"crossref","first-page":"452","DOI":"10.1007\/s12664-014-0488-5","volume":"33","author":"S Alam","year":"2014","unstructured":"Alam S, Gupta UD, Alam M, Kabir J, Chowdhury ZR, Alam AK. Clinical, anthropometric, biochemical, and histological characteristics of nonobese nonalcoholic fatty liver disease patients of Bangladesh. Indian J Gastroenterol 2014;33:452\u2013457","journal-title":"Indian J Gastroenterol"},{"key":"10147_CR24","doi-asserted-by":"crossref","first-page":"54","DOI":"10.1002\/hep.28697","volume":"65","author":"JC Leung","year":"2017","unstructured":"Leung JC, Loong TC, Wei JL, Wong GL, Chan AW, Choi PC, et al. Histological severity and clinical outcomes of nonalcoholic fatty liver disease in nonobese patients. Hepatology 2017;65:54\u201364","journal-title":"Hepatology"},{"key":"10147_CR25","doi-asserted-by":"crossref","first-page":"2169","DOI":"10.1001\/archinte.164.19.2169","volume":"164","author":"HJ Kim","year":"2004","unstructured":"Kim HJ, Kim HJ, Lee KE, Kim DJ, Kim SK, Ahn CW, et al. Metabolic significance of nonalcoholic fatty liver disease in nonobese, nondiabetic adults. Arch Intern Med 2004;164:2169\u20132175","journal-title":"Arch Intern Med"},{"key":"10147_CR26","doi-asserted-by":"crossref","first-page":"341","DOI":"10.3109\/00365521.2014.983160","volume":"50","author":"U Akyuz","year":"2015","unstructured":"Akyuz U, Yesil A, Yilmaz Y. Characterization of lean patients with nonalcoholic fatty liver disease: potential role of high hemoglobin levels. Scand J Gastroenterol 2015;50:341\u2013346","journal-title":"Scand J Gastroenterol"},{"key":"10147_CR27","first-page":"45","volume":"25","author":"E Margariti","year":"2012","unstructured":"Margariti E, Deutsch M, Manolakopoulos S, Papatheodoridis GV. Non-alcoholic fatty liver disease may develop in individuals with normal body mass index. Ann Gastroenterol 2012;25:45\u201351","journal-title":"Ann Gastroenterol"},{"key":"10147_CR28","doi-asserted-by":"crossref","first-page":"6422","DOI":"10.1038\/ncomms7422","volume":"6","author":"M Eslam","year":"2015","unstructured":"Eslam M, Hashem AM, Leung R, Romero-Gomez M, Berg T, Dore GJ, International Hepatitis C Genetics Consortium (IHCGC), et al. Interferon-\u03bb rs12979860 genotype and liver fibrosis in viral and non-viral chronic liver disease. Nat Commun 2015;6:6422","journal-title":"Nat Commun"},{"issue":"6","key":"10147_CR29","doi-asserted-by":"crossref","first-page":"1885","DOI":"10.1002\/hep.29395","volume":"66","author":"S Petta","year":"2017","unstructured":"Petta S, Valenti L, Tuttolomondo A, Dongiovanni P, Pipitone RM, Camm\u00e0 C, et al. Interferon lambda 4 rs368234815 TT>\u03b4G variant is associated with liver damage in patients with nonalcoholic fatty liver disease. Hepatology 2017;66(6):1885\u20131893","journal-title":"Hepatology"},{"issue":"2","key":"10147_CR30","doi-asserted-by":"crossref","first-page":"399","DOI":"10.1016\/j.jhep.2016.03.011","volume":"65","author":"E Tr\u00e9po","year":"2016","unstructured":"Tr\u00e9po E, Romeo S, Zucman-Rossi J, Nahon P. PNPLA3 gene in liver diseases. J Hepatol 2016;65(2):399\u2013412","journal-title":"J Hepatol"},{"issue":"2","key":"10147_CR31","doi-asserted-by":"crossref","first-page":"268","DOI":"10.1016\/j.jhep.2017.09.003","volume":"68","author":"M Eslam","year":"2018","unstructured":"Eslam M, Valenti L, Romeo S. Genetics and epigenetics of NAFLD and NASH: clinical impact. J Hepatol 2018;68(2):268\u2013279","journal-title":"J Hepatol"},{"issue":"38","key":"10147_CR32","doi-asserted-by":"crossref","first-page":"4566","DOI":"10.2174\/1381612825666190119113836","volume":"24","author":"LVC Valenti","year":"2018","unstructured":"Valenti LVC, Baselli GA. Genetics of nonalcoholic fatty liver disease: a 2018 update. Curr Pharm Des 2018;24(38):4566\u20134573","journal-title":"Curr Pharm Des"},{"key":"10147_CR33","doi-asserted-by":"crossref","first-page":"40","DOI":"10.1038\/s41575-019-0212-0","volume":"17","author":"M Eslam","year":"2020","unstructured":"Eslam M, George J. Genetic contributions to NAFLD: leveraging shared genetics to uncover systems biology. Nat Rev Gastroenterol Hepatol 2020;17:40\u201352","journal-title":"Nat Rev Gastroenterol Hepatol"},{"issue":"4","key":"10147_CR34","doi-asserted-by":"crossref","first-page":"471","DOI":"10.1080\/00365520802588133","volume":"44","author":"K Yasutake","year":"2009","unstructured":"Yasutake K, Nakamuta M, Shima Y, Ohyama A, Masuda K, Haruta N, et al. Nutritional investigation of non-obese patients with non-alcoholic fatty liver disease: the significance of dietary cholesterol. Scand J Gastroenterol 2009;44(4):471\u2013477","journal-title":"Scand J Gastroenterol"},{"issue":"4","key":"10147_CR35","doi-asserted-by":"crossref","first-page":"369","DOI":"10.1016\/j.numecd.2017.10.014","volume":"28","author":"SMB Duarte","year":"2018","unstructured":"Duarte SMB, Stefano JT, Miele L, Ponziani FR, Souza-Basqueira M, Okada LSRR, et al. Gut microbiome composition in lean patients with NASH is associated with liver damage independent of caloric intake: a prospective pilot study. Nutr Metab Cardiovasc Dis 2018;28(4):369\u2013384","journal-title":"Nutr Metab Cardiovasc Dis"},{"issue":"4","key":"10147_CR36","doi-asserted-by":"crossref","first-page":"1213","DOI":"10.1002\/hep.30908","volume":"71","author":"F Chen","year":"2020","unstructured":"Chen F, Esmaili S, Rogers GB, Bugianesi E, Petta S, Marchesini G, et al. Lean NAFLD: a distinct entity shaped by differential metabolic adaptation. Hepatology 2020;71(4):1213\u20131227","journal-title":"Hepatology"},{"issue":"3","key":"10147_CR37","doi-asserted-by":"crossref","first-page":"e0213692","DOI":"10.1371\/journal.pone.0213692","volume":"14","author":"Y Yun","year":"2019","unstructured":"Yun Y, Kim HN, Lee EJ, Ryu S, Chang Y, Shin H, et al. Fecal and blood microbiota profiles and presence of nonalcoholic fatty liver disease in obese versus lean subjects. PLoS ONE 2019;14(3):e0213692","journal-title":"PLoS ONE"},{"issue":"11\u201312","key":"10147_CR38","doi-asserted-by":"crossref","first-page":"1260","DOI":"10.1111\/apt.15015","volume":"48","author":"J Ampuero","year":"2018","unstructured":"Ampuero J, Aller R, Gallego-Dur\u00e1n R, Banales JM, Crespo J, Garc\u00eda-Monz\u00f3n C, et al. The effects of metabolic status on non-alcoholic fatty liver disease-related outcomes, beyond the presence of obesity. Aliment Pharmacol Ther 2018;48(11\u201312):1260\u20131270","journal-title":"Aliment Pharmacol Ther"},{"issue":"8","key":"10147_CR39","doi-asserted-by":"crossref","first-page":"713","DOI":"10.1016\/S2468-1253(20)30090-X","volume":"5","author":"M Eslam","year":"2020","unstructured":"Eslam M, Fan JG, Mendez-Sanchez N. Non-alcoholic fatty liver disease in non-obese individuals: the impact of metabolic health. Lancet Gastroenterol Hepatol 2020;5(8):713\u2013715","journal-title":"Lancet Gastroenterol Hepatol"},{"key":"10147_CR40","doi-asserted-by":"crossref","first-page":"427","DOI":"10.1001\/archinte.163.4.427","volume":"163","author":"YW Park","year":"2003","unstructured":"Park YW, Zhu S, Heshka S, Carnethon MR, Heymsfield SB. The metabolic syndrome: prevalence and associated risk factor findings in the US population from the third national health and nutrition examination survey, 1988\u20131994. Arch Intern Med 2003;163:427\u2013446","journal-title":"Arch Intern Med"},{"key":"10147_CR41","doi-asserted-by":"crossref","first-page":"1136","DOI":"10.1002\/hep4.1534","volume":"4","author":"P Golabi","year":"2020","unstructured":"Golabi P, Paik JM, Arshad T, Younossi Y, Mishra A, Younossi ZM. Mortality of NAFLD according to the body composition and presence of metabolic abnormalities. Hepatol Commun 2020;4:1136\u20131148","journal-title":"Hepatol Commun"},{"issue":"2","key":"10147_CR42","doi-asserted-by":"crossref","first-page":"134","DOI":"10.1007\/s11901-016-0302-1","volume":"15","author":"J Wattacheril","year":"2016","unstructured":"Wattacheril J, Sanyal AJ. Lean NAFLD: an underrecognized outlier. Curr Hepatol Rep 2016;15(2):134\u2013139","journal-title":"Curr Hepatol Rep"},{"issue":"4","key":"10147_CR43","doi-asserted-by":"crossref","first-page":"405","DOI":"10.1097\/01.mco.0000134362.76653.b2","volume":"7","author":"E Volpi","year":"2004","unstructured":"Volpi E, Nazemi R, Fujita S. Muscle tissue changes with aging. Curr Opin Clin Nutr Metab Care 2004;7(4):405\u2013410","journal-title":"Curr Opin Clin Nutr Metab Care"},{"key":"10147_CR44","doi-asserted-by":"crossref","first-page":"2","DOI":"10.21037\/hbsn.2018.11.11","volume":"8","author":"L Pacifico","year":"2019","unstructured":"Pacifico L, Perla FM, Chiesa C. Sarcopenia and nonalcoholic fatty liver disease: a causal relationship. HepatoBil Surg Nutr 2019;8:2","journal-title":"HepatoBil Surg Nutr"},{"key":"10147_CR45","doi-asserted-by":"crossref","first-page":"51","DOI":"10.1186\/s12876-018-0776-0","volume":"18","author":"R Yu","year":"2018","unstructured":"Yu R, Shi Q, Liu L, Chen L. Relationship of sarcopenia with steatohepatitis and advanced liver fibrosis in non-alcoholic fatty liver disease: a meta-analysis. BMC Gastroenterol 2018;18:51","journal-title":"BMC Gastroenterol"},{"issue":"6","key":"10147_CR46","doi-asserted-by":"crossref","first-page":"1349","DOI":"10.1016\/j.jhep.2018.08.011","volume":"69","author":"VW Wong","year":"2018","unstructured":"Wong VW, Wong GL, Chan RS, Shu SS, Cheung BH, Li LS, et al. Beneficial effects of lifestyle intervention in non-obese patients with non-alcoholic fatty liver disease. J Hepatol 2018;69(6):1349\u20131356","journal-title":"J Hepatol"},{"key":"10147_CR47","doi-asserted-by":"crossref","first-page":"1341","DOI":"10.1111\/j.1440-1746.2012.07165.x","volume":"27","author":"YJ Jin","year":"2012","unstructured":"Jin YJ, Kim KM, Hwang S, Lee SG, Ha TY, Song GW, et al. Exercise and diet modification in non-obese non-alcoholic fatty liver disease: analysis of biopsies of living liver donors. J Gastroenterol Hepatol 2012;27:1341\u20131347","journal-title":"J Gastroenterol Hepatol"},{"issue":"6","key":"10147_CR48","doi-asserted-by":"crossref","first-page":"1302","DOI":"10.3390\/nu11061302","volume":"11","author":"ML Petroni","year":"2019","unstructured":"Petroni ML, Caletti MT, Dalle Grave R, Bazzocchi A, Aparisi G\u00f3mez MP, Marchesini G. Prevention and treatment of sarcopenic obesity in women. Nutrients 2019;11(6):1302","journal-title":"Nutrients"},{"key":"10147_CR49","doi-asserted-by":"crossref","first-page":"1306","DOI":"10.1038\/ajg.2015.235","volume":"110","author":"JL Wei","year":"2015","unstructured":"Wei JL, Leung JC, Loong TC, Wong GL, Yeung DK, Chan RS, et al. Prevalence and severity of nonalcoholic fatty liver disease in non-obese patients: a population study using proton-magnetic resonance spectroscopy. Am J Gastroenterol 2015;110:1306\u20131314","journal-title":"Am J Gastroenterol"}],"container-title":["Hepatology International"],"original-title":[],"language":"en","link":[{"URL":"https:\/\/link.springer.com\/content\/pdf\/10.1007\/s12072-021-10147-0.pdf","content-type":"application\/pdf","content-version":"vor","intended-application":"text-mining"},{"URL":"https:\/\/link.springer.com\/article\/10.1007\/s12072-021-10147-0\/fulltext.html","content-type":"text\/html","content-version":"vor","intended-application":"text-mining"},{"URL":"https:\/\/link.springer.com\/content\/pdf\/10.1007\/s12072-021-10147-0.pdf","content-type":"application\/pdf","content-version":"vor","intended-application":"similarity-checking"}],"deposited":{"date-parts":[[2021,5,24]],"date-time":"2021-05-24T07:08:33Z","timestamp":1621840113000},"score":1,"resource":{"primary":{"URL":"https:\/\/link.springer.com\/10.1007\/s12072-021-10147-0"}},"subtitle":[],"short-title":[],"issued":{"date-parts":[[2021,2,4]]},"references-count":49,"journal-issue":{"issue":"2","published-print":{"date-parts":[[2021,4]]}},"alternative-id":["10147"],"URL":"https:\/\/doi.org\/10.1007\/s12072-021-10147-0","relation":{},"ISSN":["1936-0533","1936-0541"],"issn-type":[{"value":"1936-0533","type":"print"},{"value":"1936-0541","type":"electronic"}],"subject":[],"published":{"date-parts":[[2021,2,4]]},"assertion":[{"value":"29 September 2020","order":1,"name":"received","label":"Received","group":{"name":"ArticleHistory","label":"Article History"}},{"value":"18 January 2021","order":2,"name":"accepted","label":"Accepted","group":{"name":"ArticleHistory","label":"Article History"}},{"value":"4 February 2021","order":3,"name":"first_online","label":"First Online","group":{"name":"ArticleHistory","label":"Article History"}},{"order":1,"name":"Ethics","group":{"name":"EthicsHeading","label":"Compliance with ethical standards"}},{"value":"Yu-Ming Cheng, Jia-Horng Kao and     Chia-Chi Wang authors declare no conflict and interest.","order":2,"name":"Ethics","group":{"name":"EthicsHeading","label":"Conflict and interest"}},{"value":"The study was performed in accordance with the principles of the 1975 Declaration of Helsinki and approved by the Ethical Committee of Taipei Tzu Chi Hospital, Buddhist Tzu Chi Medical Foundation with waived informed consent.","order":3,"name":"Ethics","group":{"name":"EthicsHeading","label":"Ethical considerations"}},{"value":"Informed consent was obtained for all forms of personally identifiable data including biomedical, clinical, and biometric data.","order":4,"name":"Ethics","group":{"name":"EthicsHeading","label":"Consent to participate"}},{"value":"Written informed consent for publication was obtained from all participants.","order":5,"name":"Ethics","group":{"name":"EthicsHeading","label":"Consent for publication"}}]}}